Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xin Zhang, Hejing Huang, Ziran Wei, Zhenxin Zhu, Dejun Yang, Hongbing Fu, Jiapeng Xu, Zunqi Hu, Yu Zhang, Qing You, Xin Huang, Ronglin Yan, Weimin Wang & Qingping Cai. (2020) Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis. Cancer Management and Research 12, pages 6641-6653.
Read now
Read now
Michael Davidson & Ian Chau. (2018) Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches. Expert Review of Anticancer Therapy 18:4, pages 327-338.
Read now
Read now
Karen De Souza, Suha Atabani & Srinivasan Madhusudan. (2017) Precision medicine in gastric cancer: where are we now?. Expert Review of Precision Medicine and Drug Development 2:4, pages 193-204.
Read now
Read now
Articles from other publishers (49)
Caressa Hui, Agnes Ewongwo, Brianna Lau, George Fisher, Daniel Delitto, George Poultsides, Quoc-Anh Ho, Elham Rahimy, Erqi Pollom, Daniel T. Chang & Lucas K. Vitzthum. (2023) Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation. Annals of Surgical Oncology 31:1, pages 413-420.
Crossref
Crossref
Hao Zhong, Xiaodong Liu, Yulong Tian, Shougen Cao, Zequn Li, Gan Liu, Yuqi Sun, Xingqi Zhang, Zhenlong Han, Cheng Meng, Zhuoyu Jia, Qingrui Wang & Yanbing Zhou. (2023) Comparison of short- and long-term outcomes between laparoscopic and open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy: a propensity score matching analysis. Surgical Endoscopy 37:8, pages 5902-5915.
Crossref
Crossref
Ana K. Zegarra-Castillo, Juan Díaz-Plasencia, Edgar F. Yan-Quiroz & Mery Villarreal-González. (2023) Evaluación de la respuesta histológica tumoral luego de quimioterapia neoadyuvante en adenocarcinoma gástrico avanzado. UCV Scientia Biomédica 4:4, pages 26-35.
Crossref
Crossref
Alva Lim Khai Shin, Adelina Ho Si Ying, Sarah Neo Hui Wen, Shanwen Charleen Yeo & Kon Voi Tay. (2023) Systematic review and meta-analysis of the outcomes following neoadjuvant therapy in upfront resectable gastric cancers compared to surgery alone in phase III randomised controlled trials. Journal of Gastrointestinal Surgery 27:6, pages 1261-1276.
Crossref
Crossref
Dalton A. Norwood, Eleazar Montalvan-Sanchez, Ricardo L. Dominguez & Douglas R. Morgan. (2022) Gastric Cancer. Gastroenterology Clinics of North America 51:3, pages 501-518.
Crossref
Crossref
Wenpeng Huang, Liming Li, Siyun Liu, Yunjin Chen, Chenchen Liu, Yijing Han, Fang Wang, Pengchao Zhan, Huiping Zhao, Jing Li & Jianbo Gao. (2022) Enhanced CT-based radiomics predicts pathological complete response after neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction: a two-center study. Insights into Imaging 13:1.
Crossref
Crossref
Jen-Hao Yeh, Yung-Sung Yeh, Hsiang-Lin Tsai, Ching-Wen Huang, Tsung-Kun Chang, Wei-Chih Su & Jaw-Yuan Wang. (2022) Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?. Cancers 14:12, pages 3026.
Crossref
Crossref
Sunil Kumar, Naveen Kumar, Suryanarayana Deo, Sandeep Bhoriwal, Amitabha Mandal, Atul Sharma, Sushmita Pathy, Prasenjit Das, Sanjay Thulkar & Sushma Bhatnagar. (2022) Patterns of Multimodality Management of Gastric Cancer—Single Institutional Experience of 372 Cases From a Tertiary Care Center in North India. Frontiers in Oncology 12.
Crossref
Crossref
Telma Fonseca, Mariana Coimbra, Hugo Santos-Sousa, Elisabete Barbosa & José Barbosa. (2022) Impact of perioperative chemotherapy in the treatment of patients with gastric cancer. Porto Biomedical Journal 7:6, pages e180.
Crossref
Crossref
Jochen Rudi. (2021) Geriatrische gastrointestinale Onkologie: Ösophagus, Magen, DickdarmGeriatric gastrointestinal oncology: esophagus, stomach, large intestine. Der Gastroenterologe 16:5, pages 369-377.
Crossref
Crossref
Jian-Hong Yu, Zao-Zao WangYing-Chong Fan, Mao-Xing Liu, Kai Xu, Nan Zhang, Zhen-Dan Yao, Hong Yang, Cheng-Hai Zhang, Jia-Di Xing, Ming Cui & Xiang-Qian Su. (2021) Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis. Chinese Medical Journal 134:14, pages 1669-1680.
Crossref
Crossref
Felipe B. Maegawa, Yazan Ashouri, Marisa Bartz-Kurycki, Maria Ahmad, Elizabeth De La Rosa, Alexander Philipovskiy, Taylor S. Riall & Ioannis T. Konstantinidis. (2021) Impact of facility type on survival after pancreatoduodenectomy for small pancreatic adenocarcinoma (≤ 2 cm). The American Journal of Surgery 222:1, pages 145-152.
Crossref
Crossref
Haihong Liao, Pengtao Song, Quan Qi, Yizhen Jiang, Shuwen Han, Yuefen Pan & Yulong Liu. (2021) Synchronous primary malignancy of colon cancer and mantle cell lymphoma: A case report. Open Medicine 16:1, pages 696-702.
Crossref
Crossref
Adnan Zaidi, Amal Khan, Claire Duval, Kamal Haider, Osama Ahmed, Dorie-Anna Dueck, Bryan Brunet, Donald Gardiner & Shahid Ahmed. (2021) Comparison of Perioperative Chemotherapy versus Postoperative Chemoradiotherapy for Operable Stomach Cancer: A Western Canadian Province Experience. Current Oncology 28:2, pages 1262-1273.
Crossref
Crossref
Adithya Balasubramanian, Alexius John & Eva Segelov. 2021. Research and Clinical Applications of Targeting Gastric Neoplasms. Research and Clinical Applications of Targeting Gastric Neoplasms
289
316
.
Kai-Yu Sun, Hang-Tong Hu, Shu-Ling Chen, Jin-Ning Ye, Guang-Hua Li, Li-Da Chen, Jian-Jun Peng, Shi-Ting Feng, Yu-Jie Yuan, Xun Hou, Hui Wu, Xin Li, Ting-Fan Wu, Wei Wang & Jian-Bo Xu. (2020) CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer 20:1.
Crossref
Crossref
Astrid E. Slagter, Marieke A. Vollebergh, Edwin P. M. Jansen, Johanna W. van Sandick, Annemieke Cats, Nicole C. T. van Grieken & Marcel Verheij. (2020) Towards Personalization in the Curative Treatment of Gastric Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Khalil El Gharib & Hampig R Kourie. (2020) Targeting HER2 in the management of potentially resectable gastric adenocarcinoma: what are oncologists waiting for?. Future Oncology 16:33, pages 2683-2686.
Crossref
Crossref
Torben Glatz, Rasmus Verst, Jasmina Kuvendjiska, Peter Bronsert, Heiko Becker, Jens Hoeppner & Birte Kulemann. (2020) Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials. Journal of Clinical Medicine 9:8, pages 2654.
Crossref
Crossref
Preethi Vetrivel, Seong Min Kim, Sang Eun Ha, Hun Hwan Kim, Pritam Bhagwan Bhosale, Kalaiselvi Senthil & Gon Sup Kim. (2020) Compound Prunetin Induces Cell Death in Gastric Cancer Cell with Potent Anti-Proliferative Properties: In Vitro Assay, Molecular Docking, Dynamics, and ADMET Studies. Biomolecules 10:7, pages 1086.
Crossref
Crossref
E.C. Gertsen, C. de Jongh, H.J.F. Brenkman, A.C. Mertens, I.A.M.J. Broeders, M. Los, D. Boerma, D. ten Bokkel Huinink, L. van Leeuwen, F.J. Wessels, R. van Hillegersberg & J.P. Ruurda. (2020) The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer. European Journal of Surgical Oncology 46:7, pages 1247-1253.
Crossref
Crossref
Masato Kondo, Shogo Nishino, Daisuke Yamashita & Satoshi Kaihara. (2020) Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin. Case Reports in Oncology 13:2, pages 716-720.
Crossref
Crossref
Juan Ocaña Jiménez, Pablo Priego, Marta Cuadrado, Luis Alberto Blázquez, Silvia Sánchez Picot, Paula Pastor Peinado, Federico Longo, Fernando López, María Alejandra Caminoa-Lizarralde & Julio Galindo. (2020) Impact of interval timing to surgery on tumor response after neoadjuvant treatment for gastric cancer. Revista Española de Enfermedades Digestivas 112.
Crossref
Crossref
Norihiro Matsuura, Masaaki Motoori, Kazumasa Fujitani, Yujiro Nishizawa, Hisateru Komatsu, Yasuhiro Miyazaki, Susumu Miyazaki, Akira Tomokuni, Takamichi Komori & Kazuhiro Iwase. (2020) Correlation between Skeletal Muscle Mass and Adverse Events of Neoadjuvant Chemotherapy in Patients with Gastric Cancer. Oncology 98:1, pages 29-34.
Crossref
Crossref
Yiyi Yu, Yong Fang, Zhenbin Shen, Yan Wang, Min Yan, Hui Cao, Yingbin Liu, Xuefei Wang, Yuehong Cui, Fenglin Liu, Weidong Chen, Wei Li, Qian Li, Huiqin Jiang, Yihong Sun & Tianshu Liu. (2019) Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study. The Oncologist 24:10, pages 1311-e989.
Crossref
Crossref
Alicia S. Borggreve, Lucas Goense, Hylke J.F. Brenkman, Stella Mook, Gert J. Meijer, Frank J. Wessels, Marcel Verheij, Edwin P.M. Jansen, Richard van Hillegersberg, Peter S.N. van Rossum & Jelle P. Ruurda. (2019) Imaging strategies in the management of gastric cancer: current role and future potential of MRI. The British Journal of Radiology 92:1097, pages 20181044.
Crossref
Crossref
Ilaria Benevento, Nadia Bulzonetti, Francesca De Felice, Daniela Musio, Massimo Vergine & Vincenzo Tombolini. (2018) The role of different adjuvant therapies in locally advanced gastric adenocarcinoma. Oncotarget 9:74, pages 34022-34029.
Crossref
Crossref
Tyler J. Fraum, Daniel R. Ludwig, Thomas A. Hope & Kathryn J. Fowler. (2018) PET/MRI for Gastrointestinal Imaging. Gastroenterology Clinics of North America 47:3, pages 691-714.
Crossref
Crossref
Zhaolun Cai, Yiqiong Yin, Zhou Zhao, Chunyu Xin, Zhaohui Cai, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Jian Wang, Zhixin Chen, Ye Zhou & Bo Zhang. (2018) Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis. Frontiers in Pharmacology 9.
Crossref
Crossref
Ziyu Li, Fei Shan, Xiangji Ying, Lianhai Zhang, Hui Ren, Shuangxi Li, Yongning Jia, Rulin Miao, Kan Xue, Zhemin Li, Yinkui Wang, Chao Yan, Yan Zhang, Fei Pang & Jiafu Ji. (2018) Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial. BMJ Open 8:8, pages e021633.
Crossref
Crossref
O. A. Koroleva, L. M. Kogoniya, M. M. Byakhova & A. G. Titov. (2018) CHEMOTHERAPY IN ELDERLY PATIENTS WITH STOMACH CANCER. Malignant tumours 8:2, pages 64-75.
Crossref
Crossref
Qingzhi Lv, Jincheng Yang, Ruoshi Zhang, Zimeng Yang, Zhengtao Yang, Yongjun Wang, Youjun Xu & Zhonggui He. (2018) Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA–Paclitaxel Conjugate. Molecular Pharmaceutics 15:5, pages 1842-1852.
Crossref
Crossref
Katelin A. Mirkin, Erin K. Greenleaf, Christopher S. Hollenbeak & Joyce Wong. (2018) Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer. International Journal of Surgery 52, pages 221-228.
Crossref
Crossref
Ali A. Mokdad, Amna Ali, Adam C. Yopp, Patricio M. Polanco, Ibrahim Nassour, John C. Mansour, Michael A. Choti, Rebecca M. Minter, Sam C. Wang & Matthew R. Porembka. (2018) Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study. Cancer 124:6, pages 1122-1131.
Crossref
Crossref
Emmanuel Gabriel, Kristopher Attwood, Sumana Narayanan, Maureen Brady, Steven Nurkin, Steven Hochwald & Moshim Kukar. (2018) Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?. Journal of Surgical Oncology 117:4, pages 659-670.
Crossref
Crossref
Robert de W. Marsh, Mark S. Talamonti, Marshall S. Baker, Mitchell Posner, Kevin Roggin, Jeffrey Matthews, Daniel Catenacci, Mark Kozloff, Blase Polite, Michele Britto, Chi Wang & Hedy Kindler. (2018) Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. Journal of Surgical Oncology 117:3, pages 354-362.
Crossref
Crossref
Yi Liu, Ke-Cheng Zhang, Xiao-Hui Huang, Hong-Qing Xi, Yun-He Gao, Wen-Quan Liang, Xin-Xin Wang & Lin Chen. (2018) Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes. World Journal of Gastroenterology 24:2, pages 257-265.
Crossref
Crossref
Ijin Joo, Se Hyung Kim, Su Joa Ahn, Eun Sun Lee, Cheong-Il Shin, Hyuk-Joon Lee & Han Kwang Yang. (2017) Preoperative tumor restaging and resectability assessment of gastric cancers after chemotherapy: diagnostic accuracy of MDCT using new staging criteria. Abdominal Radiology 42:12, pages 2807-2815.
Crossref
Crossref
Yang Li, Jun Chen, Qi He, Xiang Ji, Xulin Wang, Chaogang Fan & Guoli Li. (2017) Clinical efficacy of neoadjuvant chemotherapy regimens FLEEOX vs. XELOX in patients with initially unresectable advanced gastric cancer: a propensity score analysis. Oncotarget 8:49, pages 86886-86896.
Crossref
Crossref
Daphna Spiegel, Manisha Palta & Hope Uronis. (2017) Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma. Surgical Clinics of North America 97:2, pages 421-435.
Crossref
Crossref
Vikas OstwalArvind SahuAnant RamaswamyBhawna SirohiSubhadeep BoseVikas TalrejaMahesh GoelShraddha PatkarAshwin DesouzaShailesh V. Shrikhande. (2017) Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis. Journal of Gastric Cancer 17:1, pages 21.
Crossref
Crossref
V. V. Oleksenko, S. V. Efetov & K. A. Aliev. (2017) About reduodenization of digestive tract in gastrectomy. Khirurgiya. Zhurnal im. N.I. Pirogova:8, pages 95.
Crossref
Crossref
Saeed Soleyman-Jahi, Afshin Abdirad, Amir Afraz Fallah, Sevil Ghasemi, Fatemeh Sadeghi, Reza Heidari, Habibollah Mahmoodzadeh & Kazem Zendehdel. (2017) Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study. Clinical and Translational Gastroenterology 8:1, pages e209.
Crossref
Crossref
Jun-hua Zhao, Peng Gao, Yong-xi Song, Jing-xu Sun, Xiao-wan Chen, Bin Ma, Yu-chong Yang & Zhen-ning Wang. (2016) Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis. BMC Cancer 16:1.
Crossref
Crossref
Syed A. Ahmad, Brent T. Xia, Christina E. Bailey, Daniel E. Abbott, Beth A. Helmink, Meghan C. Daly, Ramya Thota, Cameron Schlegal, Leah K. Winer, S. Ameen Ahmad, Ali H. Al Humaidi & Alexander A Parikh. (2016) An update on gastric cancer. Current Problems in Surgery 53:10, pages 449-490.
Crossref
Crossref
Ai-Wen Wu, Peng Yuan, Zi-Yu Li, Lei Tang, Zhao-De Bu, Hui Ren & Jia-Fu Ji. (2016) Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study. Future Oncology 12:18, pages 2107-2116.
Crossref
Crossref
T. Glatz, P. Bronsert, M. Schäfer, B. Kulemann, G. Marjanovic, O. Sick, U.T. Hopt, K. Zirlik, F. Makowiec & J. Hoeppner. (2015) Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome. European Journal of Surgical Oncology (EJSO) 41:10, pages 1300-1307.
Crossref
Crossref
Shu-bo Tian, Jian-chun Yu, Wei-ming Kang, Zhi-qiang Ma, Xin Ye, Chao Yan & Ya-kai Huang. (2015) Effect of Neoadjuvant Chemotherapy Treatment on Prognosis of Patients with Advanced Gastric Cancer: a Retrospective Study. Chinese Medical Sciences Journal 30:2, pages 84-89.
Crossref
Crossref
Marília Cravo. (2015) Towards curative therapy in gastric cancer: Faraway, so close!. World Journal of Gastroenterology 21:41, pages 11609.
Crossref
Crossref